Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K A Porter

Showing results (81-90 of 139) with videos related to

Pageof 14
Sort By:
JAMA|November 5, 1973
Massive early proteinuria following renal homotransplantationG M Abouna, H Kogure, K A Porter, et al.
Surgery|March 1, 1977
Liver replacement for alpha1-antitrypsin deficiencyC W Putnam, K A Porter, R L Peters, et al.
Transplantation Proceedings|December 1, 1991
The effects of FK 506, cyclosporine, and rapamycin on liver growth in vitro and in vivoA Francavilla, T E Starzl, B Carr, et al.
Epidemiology and Infection|July 13, 2010
Uncertain outcomes: adjusting for misclassification in antimalarial efficacy studiesK A Porter, C L Burch, C Poole, et al.
Transplantation|October 1, 1991
Hepatotrophic properties in dogs of human FKBP, the binding protein for FK506 and rapamycinT E Starzl, S L Schreiber, M W Albers, et al.
Annals of the New York Academy of Sciences|May 17, 2011
LIGHT AND ELECTRON MICROSCOPIC STUDY OF BIOPSIES FROM THIRTY-THREE HUMAN RENAL ALLOGRAFTS AND AN ISOGRAFT 134-212 YEARS AFTER TRANSPLANTATIONK A Porter, J M Rendall, C Stolinski, et al.
Pediatrics|June 1, 1979
Liver replacement for pediatric patientsT E Starzl, L J Koep, G P Schröter, et al.
Transplantation Proceedings|March 1, 1981
Liver transplantation, 1980, with particular reference to cyclosporin-AT E Starzl, S Iwatsuki, G Klintmalm, et al.
Archives of Surgery (Chicago, Ill. : 1960)|July 1, 1979
Should the ruptured renal allograft be removed?P Dryburgh, K A Porter, R A Krom, et al.
Transplantation|January 1, 1987
An assessment of Nva2-cyclosporine in primate cardiac transplantationH O Ogunnaike, T D Starkey, J C Baldwin, et al.
Pageof 14

Showing results (81-90 of 139) with videos related to

Sort By:
Pageof 14
JAMA|November 5, 1973
Massive early proteinuria following renal homotransplantationG M Abouna, H Kogure, K A Porter, et al.
Surgery|March 1, 1977
Liver replacement for alpha1-antitrypsin deficiencyC W Putnam, K A Porter, R L Peters, et al.
Transplantation Proceedings|December 1, 1991
The effects of FK 506, cyclosporine, and rapamycin on liver growth in vitro and in vivoA Francavilla, T E Starzl, B Carr, et al.
Epidemiology and Infection|July 13, 2010
Uncertain outcomes: adjusting for misclassification in antimalarial efficacy studiesK A Porter, C L Burch, C Poole, et al.
Transplantation|October 1, 1991
Hepatotrophic properties in dogs of human FKBP, the binding protein for FK506 and rapamycinT E Starzl, S L Schreiber, M W Albers, et al.
Annals of the New York Academy of Sciences|May 17, 2011
LIGHT AND ELECTRON MICROSCOPIC STUDY OF BIOPSIES FROM THIRTY-THREE HUMAN RENAL ALLOGRAFTS AND AN ISOGRAFT 134-212 YEARS AFTER TRANSPLANTATIONK A Porter, J M Rendall, C Stolinski, et al.
Pediatrics|June 1, 1979
Liver replacement for pediatric patientsT E Starzl, L J Koep, G P Schröter, et al.
Transplantation Proceedings|March 1, 1981
Liver transplantation, 1980, with particular reference to cyclosporin-AT E Starzl, S Iwatsuki, G Klintmalm, et al.
Archives of Surgery (Chicago, Ill. : 1960)|July 1, 1979
Should the ruptured renal allograft be removed?P Dryburgh, K A Porter, R A Krom, et al.
Transplantation|January 1, 1987
An assessment of Nva2-cyclosporine in primate cardiac transplantationH O Ogunnaike, T D Starkey, J C Baldwin, et al.
Pageof 14